How much has Bluejay Therapeutics raised?
$243.0Macross 3 recorded rounds · Jun 2021 – May 2024
Most recently, Bluejay Therapeutics raised $182.0M in its Later Stage VC (Series C) (May 2024).
Free account
More of Bluejay Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Bluejay Therapeutics: the Monday email on marks, rounds and moves
Bluejay Therapeutics round by round
3 roundsMay 2024Later Stage VC (Series C)$182.0M▮
+ 1 more investors · free account
9 investors participated
6 investors participated
How much has Bluejay Therapeutics raised?
Bluejay Therapeutics has raised $243 million across 3 recorded rounds since 2021. The largest was a $20.5 million early-stage round in Aug 2022; the most recent was an $182 million Series C in May 2024.
Bluejay Therapeutics has filed 3 Form Ds with the SEC since 2021, most recently in May 2024 ($182 million sold to 19 investors).
Bluejay Therapeutics investors
13 investors are on record for Bluejay Therapeutics, including RA Capital Management, Novo Holdings, Wellington Management and T. Rowe Price Group. The Series C in May 2024 drew 8 investors.
For fundraisers
Raising for a company like Bluejay Therapeutics?
13 investors have backed Bluejay Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Bluejay Therapeutics
- How much has Bluejay Therapeutics raised?
- Bluejay Therapeutics has raised $243.0M in total across 3 recorded funding rounds.
- When was Bluejay Therapeutics's last funding round?
- Bluejay Therapeutics's most recent recorded round was Later Stage VC (Series C) in May 2024, raising $182.0M.